REQUEST A DEMO
Total
USD $0.00
Search more companies

Werfen Colombia Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Werfen Colombia Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Werfen Colombia Sas is a company in Colombia, with a head office in Bogota D.C.. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on July 09, 2013. It currently has a total number of 55 (2024) employees. From the latest financial highlights, Werfen Colombia Sas reported a net sales revenue increase of 27.54% in 2023. Its total assets grew by 2.04% over the same period. In 2023, Werfen Colombia Sas’s net profit margin increased by 15.28%.

Headquarters
Cl 116 # 7 - 15 Of 1003
Bogota D.C.; Bogota D.C; Postal Code: 1002

Contact Details: Purchase the Werfen Colombia Sas report to view the information.

Basic Information
Total Employees:
Purchase the Werfen Colombia Sas report to view the information.
Outstanding Shares:
Purchase the Werfen Colombia Sas report to view the information.
Incorporation Date:
July 09, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Werfen Colombia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
27.54%
Total operating revenue
27.54%
Operating profit (EBIT)
32.9%
EBITDA
N/A
Net Profit (Loss) for the Period
68.3%
Total assets
2.04%
Total equity
-9.09%
Operating Profit Margin (ROS)
9.63%
Net Profit Margin
15.28%
Return on Equity (ROE)
14.84%
Debt to Equity Ratio
-0.97%
Quick Ratio
-0.25%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?